INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2019. The put-call ratio across all filers is 2.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $711,000 | -6.7% | 12,450 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $762,000 | +16.9% | 12,450 | 0.0% | 0.00% | – |
| Q4 2021 | $652,000 | +40.5% | 12,450 | 0.0% | 0.00% | – |
| Q3 2021 | $464,000 | -37.7% | 12,450 | -31.8% | 0.00% | -100.0% |
| Q2 2021 | $745,000 | -28.9% | 18,250 | -40.9% | 0.00% | 0.0% |
| Q1 2021 | $1,048,000 | +6.7% | 30,885 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $982,000 | +23.8% | 30,885 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $793,000 | +74.7% | 30,885 | +74.9% | 0.00% | 0.0% |
| Q2 2020 | $454,000 | -17.6% | 17,659 | -50.7% | 0.00% | 0.0% |
| Q1 2020 | $551,000 | -43.7% | 35,831 | +25.6% | 0.00% | 0.0% |
| Q4 2019 | $979,000 | +248.4% | 28,522 | -24.1% | 0.00% | – |
| Q3 2019 | $281,000 | +8.1% | 37,564 | +87.6% | 0.00% | – |
| Q2 2019 | $260,000 | -76.3% | 20,020 | -49.3% | 0.00% | -100.0% |
| Q1 2016 | $1,097,000 | -87.5% | 39,452 | -75.8% | 0.00% | -90.0% |
| Q4 2015 | $8,786,000 | +14.1% | 163,336 | -15.0% | 0.01% | +11.1% |
| Q3 2015 | $7,697,000 | – | 192,238 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |